Christopher Williams

Follow

Generating author description...

All published works

Action	Title	Year	Authors
+ PDF Chat	Factors Affecting Combination Trial Success (FACTS): Investigator Survey Results on Early-Phase Combination Trials	2019	Channing J. Paller Erich P. Huang Thomas Luechtefeld Holly A. Massett Christopher Williams Jinxiu Zhao Amy Gravell Tami Tamashiro Steven A. Reeves Gary L. Rosner

Common Coauthors

Coauthor	Papers Together
Tami Tamashiro	1
Michael A. Carducci	1
Gary L. Rosner	1
Amy Gravell	1
Holly A. Massett	1
Larry Rubinstein	1
S. Percy Ivy	1
Jinxiu Zhao	1
Channing J. Paller	1
Erich P. Huang	1
Thomas Luechtefeld	1
Steven A. Reeves	1

Commonly Cited References

Action	Title	Year	Authors	# of times referenced
+	Dose-escalation models for combination phase I trials in oncology	2010	Paul Hamberg Mark J. Ratain Emmanuel Lesaffre Jaap Verweij	1
+ PDF Chat	Extent of publication bias in different categories of research cohorts: a meta-analysis of empirical studies	2009	Fujian Song Sheetal Parekh‐Bhurke Lee Hooper Yoon K. Loke Jon J Ryder Alex J. Sutton Caroline Hing Ian Harvey	1
+ PDF Chat	Challenges and Pitfalls of Combining Targeted Agents in Phase I Studies	2008	Stephen A. Cannistra	1
+ PDF Chat	Design of Phase I Combination Trials: Recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering Committee	2014	Channing J. Paller Penelope A. Bradbury S. Percy Ivy Lesley Seymour Patricia LoRusso Laurence H. Baker Larry Rubinstein Erich Huang Deborah Collyar Susan Groshen	1
+	Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing	1995	Yoav Benjamini Yosef Hochberg	1
+ PDF Chat	Analysis of the Yield of Phase II Combination Therapy Trials in Medical Oncology	2010	Michael L. Maitland Christine Hudoba Kelly L. Snider Mark J. Ratain	1
+	Designs of drug-combination phase I trials in oncology: a systematic review of the literature	2014	Marie-Karelle Rivière Christophe Le Tourneau Xavier Paolettí Frédéric Dubois Sarah Zohar	1
+	Factors associated with failure of oncology drugs in late-stage clinical development: A systematic review	2016	Denis L. Jardim Eric S. Groves Philip P. Breitfeld Razelle Kurzrock	1